Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope-based grass pollen allergy vaccine with allergen extract-based vaccines

J Allergy Clin Immunol. 2017 Nov;140(5):1433-1436.e6. doi: 10.1016/j.jaci.2017.03.048. Epub 2017 May 31.

Authors

Milena Weber¹, Katarzyna Niespodziana¹, Birgit Linhart¹, Angela Neubauer², Hans Huber², Rainer Henning², Rudolf Valenta³, Margarete Focke-Tejkl¹

Affiliations

¹ Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
² Biomay AG, Vienna, Austria.
³ Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. Electronic address: [email protected].

No abstract available

Publication types

Comparative Study
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adjuvants, Immunologic / administration & dosage
Allergens / immunology*
Aluminum Hydroxide / administration & dosage
Animals
Epitopes, B-Lymphocyte / immunology*
Humans
Immunoglobulin G / immunology
Plant Proteins / immunology*
Poaceae / immunology*
Pollen / immunology*
Rabbits
Rhinitis, Allergic, Seasonal / immunology
Rhinitis, Allergic, Seasonal / prevention & control*
Vaccines / administration & dosage*

Substances

Adjuvants, Immunologic
Allergens
Epitopes, B-Lymphocyte
Immunoglobulin G
Plant Proteins
Vaccines
Aluminum Hydroxide

Grants and funding